Report on operations 2005:

Q4: Sales increased by 23 percent

• Turnover increased during the fourth quarter by 23 percent to SEK 30.1 (24.6) million. For the full year 2005 turnover amounted to SEK 120.1 (103.9) million, an increase of 16 percent. • Gross income for the fourth quarter increased by 20 percent to SEK 21.0 (17.4) million and the gross margin was 70 (71) percent. Gross income for the full year 2005 increased by 11 percent to SEK 82.9 (74.4) million and the gross margin amounted to 69 (72) percent. • Operating income amounted to SEK 2.4 (1.8) million for the fourth quarter and to SEK 12.1 (13.8) million for the full year 2005. • Income after financial items was SEK 2.9 (0.3) million for the fourth quarter and SEK 15.3 (12.5) million for the full year 2005. • Net income for the Group was SEK 2.9 million (0.2) for the fourth quarter and SEK 14.9 (12.7) million for the full year 2005, which corresponds to a 17 percent increase. • Earnings per share for the full year increased to SEK 0.81 (0.69). • The equity/assets ratio increased to 83 percent (81). • Cash flow during the fourth quarter amounted to SEK 2.5 (0.0) million, which means that the cash flow for the whole year was also positive, SEK 3.1 (-6.5) million. • The Board proposes that no dividend be paid for the financial year 2005. • Swemed was acquired after the end of the period. Swemed manufactures and markets medical device products for in vitro fertilization, with a turnover of SEK 31.5 million during 2005. • A new product within the transplantation area, Steen Solution™, was approved for sales in Europe in January 2006. February 22, 2006 Kungsbacka, Sweden The Board Contact persons: Magnus Nilsson, CEO, phone +46 31 721 80 00 or +46 708 22 80 61. Anna Ahlberg, CFO, phone +46 31 721 80 13 or +46 708 22 80 13.